Pasar al contenido principal

FUNCION DE LA CROMATINA EN LA INESTABILIDAD GENOMICA ASOCIADA A TRANSCRIPCION

PID2022-138251NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human SKI component SKIV2L regulates telomeric DNA-RNA hybrids and prevents telomere fragility

  • Herrera-Moyano, Emilia
  • Porreca, Rosa Maria
  • Ranjha, Lepakshi
  • Skourti, Eleni
  • Gonzalez-Franco, Roser
  • Stylianakis, Emmanouil
  • Sun, Ying
  • Li, Ruihan
  • Saleh, Almutasem
  • Montoya, Alex
  • Kramer, Holger
  • Vannier, Jean-Baptiste
Super killer (SKI) complex is a well-known cytoplasmic 3'-5' mRNA decay complex that functions with the exosome to degrade excessive and aberrant mRNAs, is implicated with the extraction of mRNA at stalled ribosomes, tackling aberrant translation. Here, we show that SKIV2L and TTC37 of the hSKI complex are present within the nucleus, localize on chromatin and at some telomeres during the G2 cell cycle phase. In cells, SKIV2L prevents telomere replication stress, independently of its helicase domain, and increases the stability of telomere DNA-RNA hybrids in G2. We further demonstrate that purified hSKI complex binds telomeric DNA and RNA substrates in vitro and SKIV2L association with telomeres is dependent on DNA-RNA hybrids. Taken together, our results provide a nuclear function for SKIV2L of the hSKI complex in overcoming replication stress at telomeres mediated by its recruitment to DNA-RNA hybrid structures in G2 and thus maintaining telomere stability., Vannier lab’s work is supported by the London Institute of Medical Sciences (LMS), which receives its core funding from UKRI (MRC), by an ERC Starter grant (637798; MetDNASecStr) and is thankful to Imperial College London for its support. Roser Gonzalez-Franco received an MRC funded PhD fellowship, Jean-Baptiste Vannier and Lepakshi Ranjha are funded by UKRI and Imperial College London. Emilia Herrera-Moyano, Rosa Maria Porreca, Eleni Skourti are funded by ERC Starter grant (637798; MetDNASecStr). Manos Stylianakis is funded by an MRC PhD fellowship. The revision work for this manuscript was carried away by Emilia Herrera-Moyano and funded by a grant from the Spanish Agencia Estatal de Investigación (AEI; PID2022-138251NB-I00 funded by Ministerio de Ciencia e Innovación/AEI/10.13039/501100011033; “ERDF: a way of making Europe”). Special thank you to Andrés Aguilera and Aguilera's laboratory (CABIMER, Universidad de Sevilla) for highly constructive discussions and for hosting the revision. We thank Titia de Lange for providing HeLa1.3 cells, Petr Cejka for Sf9 insect cells, Joachim Lingner for HT1080-ST cells and Robert J Crouch for RNase H1-overexpressing plasmids., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

RNA biogenesis and RNA metabolism factors as R-loop suppressors: a hidden role in genome integrity

  • Luna, Rosa
  • Gómez-González, Belén
  • Aguilera, Andrés
Genome integrity relies on the accuracy of DNA metabolism, but as appreciated for more than four decades, transcription enhances mutation and recombination frequencies. More recent research provided evidence for a previously unforeseen link between RNA and DNA metabolism, which is often related to the accumulation of DNA-RNA hybrids and R-loops. In addition to physiological roles, R-loops interfere with DNA replication and repair, providing a molecular scenario for the origin of genome instability. Here, we review current knowledge on the multiple RNA factors that prevent or resolve R-loops and consequent transcription-replication conflicts and thus act as modulators of genome dynamics., A.A.’s laboratory is funded by grants fromthe Spanish Agencia Estatal de Investigación (AEI; PID2022- 138251NB-I00 funded by Ministerio de Ciencia e Innovación/ AEI/10.13039/501100011033; “ERDF: a way of making Europe”), the Caixa Research Foundation (LCF/PR/HR22/52420014), and the Vencer el Cancer Foundation. The Andalusian Center of Molecular Biology and Regenerative Medicine is a center partially funded by the Junta de Andalucía., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The molecular chaperone ALYREF promotes R-loop resolution and maintains genome stability

  • Bhandari, Jay
  • Guillén-Mendoza, Cristina
  • Banks, Kathryn
  • Eliaz, Lillian
  • Southwell, Sierra
  • Eyaa, Darriel
  • Luna, Rosa
  • Aguilera, Andrés
  • Xue, Xiaoyu
Unscheduled R-loops usually cause DNA damage and replication stress, and are therefore a major threat to genome stability. Several RNA processing factors, including the conserved THO complex and its associated RNA and DNA-RNA helicase UAP56, prevent R-loop accumulation in cells. Here, we investigate the function of ALYREF, an RNA export adapter associated with UAP56 and the THO complex, in R-loop regulation. We demonstrate that purified ALYREF promotes UAP56-mediated R-loop dissociation in vitro, and this stimulation is dependent on its interaction with UAP56 and R-loops. Importantly, we show that ALYREF binds DNA-RNA hybrids and R-loops. Consistently, ALYREF depletion causes R-loop accumulation and R-loop-mediated genome instability in cells. We propose that ALYREF, apart from its known role in RNA metabolism and export, is a key cellular R-loop coregulator, which binds R-loops and stimulates UAP56-driven resolution of unscheduled R-loops during transcription., This study was funded by the National Institute of General Medical Sciences and National Institute of Environmental Health Sciences of the National Institutes of Health under Award Number R15GM139135 and R21 ES028792, and startup funds and REP program from Texas State University (to X. X.), and the Spanish Agencia Estatal de Investigación (projects I + D + i PID2019-104270GB-I00/BMC from MCIN/AEI/10.13039/501100011033/and PID2022-138251NB-I00 from MICIU/AEI/10.13039/501100011033/and FEDER, UE), the European Research Council (ERC2014 AdG669898 TARLOOP) and Foundation ‘‘Vencer el Cáncer’’ (to A. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. C. G.-M was supported by predoctoral FPU contract from the Spanish Ministry of Education, Culture and Sports, and D. E. was supported by NIH R25 GM102783 Bridge to Doctorate Program., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

R-loop homeostasis in genome dynamics, gene expression and development

  • Aguilera, Paula
  • Aguilera, Andrés
R-loops are double-edge swords with functional roles that in many cases constitute a threat to genome integrity and gene expression with relevant consequences in cell physiology and development. A number of factors have evolved to control R-loop homeostasis by acting at the levels of R-loop prevention, resolution, or the repair of the R-loop-induced DNA lesion. Deciphering the role of R-loops generated under different stresses and the plethora of processes controlling their homeostasis has become crucial to evaluate their impact in cell physiology and the biological significance of their association with development and disease. Here, we review publications of the last 2 years that help understand their biological role., Research in A.A.’s lab is funded by grants from the Spanish Agencia Estatal de Investigación (PID2022-138251NB-I00 funded by MCIN/AEI/10.13039/501100011033 ‘ERDF A way of making Europe’) and the Caixa Research Foundation (LCF/PR/HR22/52420014). P.A. is supported by a grant from the Scientific Foundation of the Spanish Association Against Cancer (POSTD234422AGUI)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Patulin and Xestoquinol are inhibitors of DNA topoisomerase 1

  • Tumini, Emanuela
  • Wellinger, Ralf Erik
  • Herrera-Moyano, Emilia
  • Navarro-Cansino, Patricia
  • García-Rubio, María
  • Salas-Lloret, Daniel
  • Losada, Alejandro
  • Muñoz-Alonso, María J.
  • Gaillard, Hélène
  • Luna, Rosa
  • Aguilera, Andrés
DNA topoisomerase 1 (TOP1) is essential for transcription, replication, and repair. Its function relies on two catalytic steps, DNA breakage and rejoining. Inhibitors of the second step prevent DNA rejoining and lead to persistent DNA breaks, acting as topoisomerase poisons, used as anticancer drugs. However, reliable inhibitors of the first step are not available. Here, we provide genetic and molecular evidence supporting that Patulin and, to a lesser extent, Xestoquinol inhibit the first catalytic step of TOP1 in vitro, in yeast and in human cells. Particularly, Patulin prevents the accumulation of TOP1 cleavage complexes caused by the TOP1 poison camptothecin (CPT) in human cells. Moreover, Patulin pretreatment of human or yeast cells reduces DNA damage and the accumulation of DNA breaks upon CPT exposure. Consistent with the protective role of TOP1 against harmful R-loops, Patulin treatment increases R-loops and R-loop-associated cytotoxicity, mimicking the effect of TOP1 silencing. Altogether our findings indicate that Patulin and Xestoquinol are nonpoisoning inhibitors of TOP1, which should potentiate new research approaches in molecular biology and medicine., We thank Belén Gómez-González, José Terrón-Bautista, and Carmen Cuevas for their constructive discussions. This work was funded by the Spanish Ministry MINECO (Program Retos-Colaboración, project RTC-2016-4611-1, INMUNOTOP), Foundation “Vencer el Cancer,” Fundación de Investigación de la Universidad de Sevilla, and the European Research Council (ERC2014 AdG669898 TARLOOP) grants to A.A. In addition, the study was partially funded by the Spanish Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033 “ERDF A way of making Europe”) grants PID2019-104270GB-I00/BMC and PID2022-138251NB-I00 to A.A. and PID2022-140466NB-I00 to R.E.W. and H.G., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcription-Replication Conflicts: Unlocking New Frontiers in Cancer

  • Bayona-Feliu, Aleix
  • Aguilera, Andrés
Genome instability (GIN) is a cell pathology linked to cancer promotion and tumor evolution. Transcription is an essential cellular process but also a potential source of DNA damage and GIN. Transcription-replication conflicts (TRCs) are a predominant source of GIN, and defective TRC resolution may seriously compromise genome integrity. Importantly, chromatin dynamics helps orchestrate the response to TRCs to preserve genome integrity. Multiple epigenetic deficiencies have been shown to cause transcription-induced replication stress, resulting in DNA breaks and mutations. Consistently, chromatin alterations are frequent in cancer and correlate with increased mutation burden at TRC sites in tumors. Here, we review our current knowledge of TRC processing, the consequences of its dysfunction, and its relevance in cancer. We focus on the interplay between the DNA damage response (DDR) and chromatin dynamics and discuss the clinical potential of targeting TRCs as anticancer strategies and drugging the associated epigenetic signatures., Research in A.A.’s lab is funded by grants from the Spanish Agencia Estatal de Investigación (PID2022-138251NB-I00 funded by MCIN/AEI/10.13039/501100011033 “ERDF A way of making Europe”) and the Caixa Research Foundation (LCF/PR/HR22/52420014). A.B.-F. was supported in part by a Juan de la Cierva postdoctoral contract (IJC2020-044963-I) from the Spanish Ministry of Science and Innovation. This review is a follow-up to “The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts,” Bayona-Feliu et al., Nat. Commun. 2023., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

An essential gene screening identifies yeast Mot1 as a suppressor of R-loops and genome instability

  • Soler-Oliva, María E.
  • Domínguez-Sierra, Rocío A.
  • Gaillard, Hélène
  • Aguilera, Andrés
Transcription is essential for cellular function, but it can also lead to genetic instability, particularly through the formation of secondary structures such as R-loops, which consist of an RNA-DNA hybrid and a displaced DNA strand. Unscheduled R-loop accumulation is a major source of DNA damage and has been associated with several human diseases, including cancer. While multiple factors involved in RNA biogenesis, export, and chromatin remodeling play a role in preventing R-loop accumulation, the function of essential proteins in R-loop metabolism remains unexplored. Here, we performed a genetic screening in Saccharomyces cerevisiae using over 1200 temperature-sensitive mutants to identify novel proteins involved in the prevention of R-loop-associated genomic instability. Our results reveal that the SWI/SNF-like protein Mot1 plays a key role in preventing R-loop accumulation and R-loop-associated genome instability. Its role is particularly important during S phase, where Mot1 dysfunction leads to R-loop dependent replication impairment, presumably due to transcription-replication conflicts (TRCs). Epistatic relationships between mutations in MOT1 and the S-phase specific DNA-RNA helicase SEN1 further support the role of Mot1 in TRCs. The study highlights the importance of transcriptional regulators in maintaining genome stability by mitigating TRCs and regulating R-loop homeostasis., This work was made with grant PID2022-138251NB-I00 funded by MICIU/AEI/10.13039/501100011033 and “ERDF/EU” as well as PID2019-104270GB-I00/BMC from the same program and grants from the European Research Council (ERC2014 AdG669898 TARLOOP), and Fundación de Investigación de la Universidad de Sevilla (FIUS22/0178) to A.A. Research was additionally supported by grant PID2022-140466NB-I00 funded by MICIU/AEI/10.13039/501100011033 and “ERDF/EU” to H.G. R.A.D-S. is recipient of a predoctoral PIF contract funded by the University of Seville (VII PPIT-US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

FANCD2 restrains fork progression and prevents fragility at early origins upon re-replication

  • Badra-Fajardo, Nibal
  • Karydi, Elena
  • Bayona-Feliu, Aleix
  • Gómez-González, Belén
  • Preza, Ourania
  • Arbi, Marina
  • Kalogeropoulou, Argyro
  • Rantala, Juha K.
  • Taraviras, Stavros
  • Aguilera, Andrés
  • Lygerou, Zoi
DNA replication is tightly regulated to ensure a single round of chromosome duplication per cell division. DNA licensing restricts origin firing to once-per-cell-cycle while aberrant licensing promotes re-replication and genome instability. Here, we investigate the mechanisms that protect genome integrity following re-replication induced by depletion of the licensing inhibitor Geminin. We find that re-replicating cells require FANCD2 to prevent genome instability. FANCD2 is rapidly recruited to chromatin upon Geminin loss, where it limits unrestrained fork progression and prevents single strand DNA gap accumulation and fork breakage. Genome-wide analyses reveal that upon re-replication, FANCD2 localizes to early origins within highly transcribed regions prone to accumulate R-loops and enriched in early replicating fragile sites. Importantly, reducing transcription and R-loops alleviates re-replication-induced genome fragility, whereas PARP inhibition exacerbates it. Our study uncovers a role for FANCD2 in safeguarding genome integrity during re-replication, offering avenues for selective targeting of cancer cells., We thank the Advanced Light Microscopy facility at the Medical School of the University of Patras for their support with experiments and the members of our groups for insightful discussions. We are also grateful to Dr. Raphael Ceccaldi for sharing the PD20 cells, Dr. Bert van de Kooij for sharing the FANCD2-KO and corrected U2OS cells and Dr. Vassilis Roukos for scientific advice in the generation of the mAID-Geminin HCT116 cells. This study was supported by research funding from the European Union Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No. 722729, the European Union Horizon Europe (2021-2027), “ESPERANCE” ERA Chair program (GA 101087215), the Hellenic Foundation for Research and Innovation (H.F.R.I.) under the “2nd Call for H.F.R.I. Research Projects to support Faculty Members & Researchers” (Project Number: 2728) and the project TAEDR-0539180 implemented within the framework of “Actions in interdisciplinary scientific areas with special interests for the connection with the productive fabric”, Greece 2.0 - National Recovery and Resilience Plan to Z.L. N.B.F. received fellowships from the Federation of European Biochemical Societies (FEBS) and the Operational Programme «Human Resources Development, Education and Lifelong Learning 2014- 2020» (IKY). This work was also funded by grants from the Spanish Agencia Estatal de Investigación (PID2022-138251NB-I00 funded by MCIN/AEI/10.13039/501100011033 “ERDF A way of making Europe”) and the Caixa Research Foundation (LCF/PR/HR22/52420014) to A.A. The publication fees of this manuscript have been financed by the Research Council of the University of Patras., Peer reviewed